• Lilly to Acquire CoLucid americanpharmaceuticalreview
    January 20, 2017
    Eli Lilly and CoLucid Pharmaceuticals have announced an agreement for Lilly to acquire CoLucid for $46.50 per share or approximately $960 million.
PharmaSources Customer Service